Co-Authors
This is a "connection" page, showing publications co-authored by Kanta Subbarao and Adam Wheatley.
Connection Strength
1.231
-
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat Commun. 2021 03 03; 12(1):1403.
Score: 0.233
-
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021 02 19; 12(1):1162.
Score: 0.233
-
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434.
Score: 0.223
-
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes. J Virol. 2018 05 01; 92(9).
Score: 0.191
-
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021 08 23; 6(16).
Score: 0.060
-
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021 07; 27(7):1205-1211.
Score: 0.059
-
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
Score: 0.059
-
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clin Transl Immunology. 2021; 10(3):e1258.
Score: 0.058
-
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
Score: 0.058
-
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol. 2020 12; 20(12):727-738.
Score: 0.057